SVF-002

N/A

Report date: 2026/05/12 15:11:39

Base Information

Drug NameSVF-002
Drug Alias NameSVF-002
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionSARS-CoV-2 Spike glycoprotein receptor binding domain modulators
TargetsSARS-CoV-2 Spike glycoprotein receptor binding domain
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSvenska Vaccinfabriken Produktion AB
China Registration ClassN/A

Develop Information

Active CompaniesKarolinska University Hospital Stockholm (Co-Sponsor, Sweden)Svenska Vaccinfabriken Produktion AB
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A